QQ客服 官方微博 反馈留言

	UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy
	Yu, Qianqian; Zhang, Tao; Xie, Conghua; Qiu, Hong; Liu, Bo; Huang, Liu; Peng, Ping; Feng, Jueping; Chen, Jigui; Zang, Aihua
刊名	CANCER CHEMOTHERAPY AND PHARMACOLOGY
	2018
卷号	82期号:1
关键词	UGT1A Polymorphism Irinotecan Outcome Metastatic colorectal cancer
ISSN号	0344-5704
DOI	10.1007/s00280-018-3595-7
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4213359
专题	武汉大学
推荐引用方式 GB/T 7714	Yu, Qianqian,Zhang, Tao,Xie, Conghua,et al. UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY,2018,82(1).
APA	Yu, Qianqian.,Zhang, Tao.,Xie, Conghua.,Qiu, Hong.,Liu, Bo.,...&Yuan, Xianglin.(2018).UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy.CANCER CHEMOTHERAPY AND PHARMACOLOGY,82(1).
MLA	Yu, Qianqian,et al."UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy".CANCER CHEMOTHERAPY AND PHARMACOLOGY 82.1(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。